Jan Van De Winkel

This inventor holds 45 USPTO granted patents and 44 published patent applications, plus 15 CIPO patents and 34 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Genmab A+s, Hoffmann-La Roche Inc., Roche Palo Alto LLC. Active years: 2008-2024.

USPTO Granted Patents = 45 (Patent Applications = 44)

% Patents Active = 86.7

CIPO Patents = 15 (Patent Applications = 5)

EPO Patents = 34 (Patent Applications = 45)

Average Co-Inventor Count = 8.4

ph-index = 14

Forward Citations = 639(Granted Patents)

Location History:

Zeist, NL (2008 - 2022)
Utrecht, NL (2015 - 2024)

Company Filing History:

Hoffmann-La Roche Inc.

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Bispecific Antibodies

Heterodimeric Antibodies

IgG4 Antibodies

Antibody Variants

Cancer Treatment

Human Antibodies

Anti-P-Selectin Antibodies

CD38 Antibodies

HER2 Antibodies

CD32b Antibodies

Drug Conjugates

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11866514 - Heterodimeric antibody Fc-containing proteins and methods for production thereof (2024-01-09),

2. 11512140 - Monoclonal antibodies against c-Met (2022-11-29),

3. 11230604 - Antibodies against human CD38 (2022-01-25),

4. 11091553 - Monoclonal antibodies against HER2 (2021-08-17),

5. 11046771 - Monoclonal antibodies against HER2 (2021-06-29),

6. 10906991 - Bispecific antibodies and methods for production thereof (2021-02-02),

7. 10793640 - Monoclonal antibodies against HER2 epitope (2020-10-06),

8. 10752695 - Stable IgG4 antibodies (2020-08-25),

9. 10597464 - Heterodimeric antibody Fc-containing proteins and methods for production thereof (2020-03-24),

10. 10351629 - Recombinant IgG4 monovalent antibodies (2019-07-16),

11. 10155816 - Recombinant monovalent antibodies and methods for production thereof (2018-12-18),

12. 10000570 - Antibody variants having modifications in the constant region (2018-06-19),

13. 9944711 - Antibodies against human CD38 (2018-04-17),

14. 9862769 - Monoclonal antibodies against HER2 (2018-01-09),

15. 9714297 - Human antibodies against tissue factor and methods of use thereof (2017-07-25),

Title: Jan Van De Winkel - Innovative Inventor from Zeist, NL

Introduction: Jan Van De Winkel is a renowned inventor hailing from Zeist, Netherlands, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jan Van De Winkel holds several patents in the areas of biotechnology, medical devices, and sustainable energy solutions, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Jan Van De Winkel has worked with leading research institutions and companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Jan Van De Winkel has collaborated with top universities, multinational companies, and talented individuals, fostering a culture of innovation and excellence in all his endeavors.

Conclusion: Jan Van De Winkel's passion for innovation, coupled with his relentless drive to push boundaries, has solidified his reputation as a visionary inventor in the global tech community.